0001615774-18-006729.txt : 20180720 0001615774-18-006729.hdr.sgml : 20180720 20180720165019 ACCESSION NUMBER: 0001615774-18-006729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180720 FILED AS OF DATE: 20180720 DATE AS OF CHANGE: 20180720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Opportunity Fund, L.P. CENTRAL INDEX KEY: 0001726403 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962923 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650-688-0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Opportunity, LLC CENTRAL INDEX KEY: 0001728970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962924 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE STREET 2: SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 6506880818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE STREET 2: SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Capital Surplus Fund VIII, L.P. CENTRAL INDEX KEY: 0001628048 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962925 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650 688 0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Capital Fund VIII, L.P. CENTRAL INDEX KEY: 0001618788 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962926 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650 688 0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Capital, LLC CENTRAL INDEX KEY: 0001674712 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962927 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650-688-0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vivo Capital VIII, LLC CENTRAL INDEX KEY: 0001618789 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 18962928 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650 688 0822 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263744114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6197 CORNERSTONE COURT, SUITE 111 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-450-6464 MAIL ADDRESS: STREET 1: 6197 CORNERSTONE COURT, SUITE 111 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 s111487_form4.xml 4 X0306 4 2018-07-20 0 0001658247 Crinetics Pharmaceuticals, Inc. CRNX 0001618789 Vivo Capital VIII, LLC C/O VIVO CAPITAL LLC 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 0001674712 Vivo Capital, LLC 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 0001618788 Vivo Capital Fund VIII, L.P. 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 0001628048 Vivo Capital Surplus Fund VIII, L.P. 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 0001728970 Vivo Opportunity, LLC 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 0001726403 Vivo Opportunity Fund, L.P. 505 HAMILTON AVENUE, SUITE 207 PALO ALTO CA 94301 0 0 1 0 Common Stock 2018-07-20 4 C 0 2560613 A 2560613 I See Footnote Common Stock 2018-07-20 4 C 0 353590 A 353590 I See Footnote Common Stock 2018-07-20 4 C 0 413040 A 2973653 I See Footnote Common Stock 2018-07-20 4 C 0 57035 A 410625 I See Footnote Common Stock 2018-07-20 4 P 0 51686 17.00 A 3025339 I See Footnote Common Stock 2018-07-20 4 P 0 7137 17.00 A 417762 I See Footnote Common Stock 2018-07-20 4 P 0 141177 17.00 A 141177 I See Footnote Common Stock 2018-07-20 4 P 0 153180 20.73 A 294357 I See Footnote Series A Preferred Stock 2018-07-20 4 C 0 8424416 D Common Stock 2560613 0 I See Footnote Series A Preferred Stock 2018-07-20 4 C 0 1163311 D Common Stock 353590 0 I See Footnote Series B Preferred Stock 2018-07-20 4 C 0 1358903 D Common Stock 413040 0 I See Footnote Series B Preferred Stock 2018-07-20 4 C 0 187648 D Common Stock 57035 0 I See Footnote The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 3.29 to 1 share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date. These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. Vivo Capital LLC is the management company of Vivo LLC. The voting members of each of Vivo Capital LLC and Vivo LLC are Frank Kung, Albert Cha, Edgar Engleman, Chen Yu and Shan Fu, none of whom has individual voting or investment power with respect to these securities. Jack B. Nielsen, M.Sc., a director of the Issuer, is a Managing Director at Vivo Capital LLC. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Vivo Opportunity, LLC is the general partner of VOF. Vivo Capital LLC is the management company of Vivo Opportunity, LLC. The voting members of Vivo Opportunity, LLC are Frank Kung, Albert Cha, Shan Fu, Gaurav Aggarwal and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $24.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. /s/ Albert Cha as managing member of Vivo Capital VIII, LLC 2018-07-20 /s/ Albert Cha as managing member of Vivo Capital LLC 2018-07-20 /s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Fund VIII, L.P. 2018-07-20 /s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Surplus Fund VIII, L.P. 2018-07-20 /s/ Albert Cha as a managing member of Vivo Opportunity, LLC 2018-07-20 /s/ Albert Cha as a managing member of Vivo Opportunity, LLC, the general partner of Vivo Opportunity Fund, L.P. 2018-07-20